Effect of 21-day exposure of phenobarbital, carbamazepine and phenytoin on P-glycoprotein expression and activity in the rat brain

Journal of the Neurological Sciences

Volumn 270, Issue 1-2, 2008, Pages 99-106

  Wen, Tao ^a   Liu, Yu Chun ^a   Yang, Hui Wen ^a   Liu, Hai Yan ^a   Liu, Xiao Dong ^a   Wang, Guang Ji ^a   Xie, Lin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Antiepileptic drugs; Blood brain barrier; Induction; P glycoprotein; Rhodamine 123

Indexed keywords

CARBAMAZEPINE; GLYCOPROTEIN P; PHENOBARBITAL; PHENYTOIN; RHODAMINE 123;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; GENE EXPRESSION; MALE; P-GLYCOPROTEIN; PHENOBARBITAL; PHENYTOIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 44649172107     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.02.016     Document Type: Article

References (47)

1. Regesta G., and Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 34 (1999) 109-122
2. Löscher W., and Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301 (2002) 7-14
3. Tishler D.M., Weinberg K.I., Hinton D.R., Barbaro N., Annett G.M., and Raffel C. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36 (1995) 1-6
4. Sisodiya S.M., Lin W.R., Harding B.N., Squier M.V., and Thom M. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125 (2002) 22-31
5. Rogawski M.A. Does P-glycoprotein play a role in pharmacoresistance to antiepileptic drugs?. Epilepsy Behav 3 (2002) 493-495
6. Dombrowski S.M., Desai S.Y., Marroni M., Cucullo L., Goodrich K., Bingaman W., et al. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42 (2001) 1501-1506
7. Brandt C., Bethmann K., Gastens A.M., and Löscher W. The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis 24 (2006) 202-211
8. van Vliet E.A., van Schaik R., Edelbroek P.M., Redeker S., Aronica E., Wadman W.J., et al. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia 47 (2006) 672-680
9. Liu X., Yang Z., Yang J., and Yang H. Increased P-glycoprotein expression and decreased phenobarbital distribution in the brain of pentylenetetrazole-kindled rats. Neuropharmacology 53 (2007) 657-663
10. Volk H., Potschka H., and Löscher W. Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables. J Histochem Cytochem 53 (2005) 517-531
11. Volk H.A., Burkhardt K., Potschka H., Chen J., Becker A., and Löscher W. Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures. Neuroscience 123 (2004) 751-759
12. Volk H.A., Potschka H., and Löscher W. Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats. Epilepsy Res 58 (2004) 67-79
13. Fromm M.F. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther 38 (2000) 69-74
14. Aquilante C.L., Letrent S.P., Pollack G.M., and Brouwer K.L. Increased brain P-glycoprotein in morphine tolerant rats. Life Sci 66 (2000) PL47-PL51
15. Demeule M., Brossard M., and Beliveau R. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am J Physiol 277 (1999) F832-F840
16. Abolhoda A., Wilson A.E., Ross H., Danenberg P.V., Burt M., and Scotto K.W. Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin Cancer Res 5 (1999) 3352-3356
17. Rizzi M., Caccia S., Guiso G., Richichi C., Gorter J.A., Aronica E., et al. Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance. J Neurosci 22 (2002) 5833-5839
18. Seegers U., Potschka H., and Löscher W. Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions. Eur J Pharmacol 451 (2002) 149-155
19. Nissinen J., and Pitkanen A. Effect of antiepileptic drugs on spontaneous seizures in epileptic rats. Epilepsy Res 73 (2007) 181-191
20. Srivastava A.K., Gupta S.K., Jain S., and Gupta Y.K. Effect of melatonin and phenytoin on an intracortical ferric chloride model of posttraumatic seizures in rats. Methods Find Exp Clin Pharmacol 24 (2002) 145-149
21. Yamashita H., Ohno K., Amada Y., Inami H., Shishikura J., Sakamoto S., et al. Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats. Naunyn Schmiedebergs Arch Pharmacol 370 (2004) 99-105
22. Ando H., Nishio Y., Ito K., Nakao A., Wang L., Zhao Y.L., et al. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrob Agents Chemother 45 (2001) 3462-3467
23. Liu H., Xu X., Yang Z., Deng Y., Liu X., and Xie L. Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats. Brain Res 1123 (2006) 245-252
24. Aronica E., Gorter J.A., Jansen G.H., van Veelen C.W., van Rijen P.C., Leenstra S., et al. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 118 (2003) 417-429
25. Aronica E., Gorter J.A., Ramkema M., Redeker S., Ozbas-Gerceker F., van Vliet E.A., et al. Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 45 (2004) 441-451
26. Sisodiya S.M., and Thom M. Widespread upregulation of drug-resistance proteins in fatal human status epilepticus. Epilepsia 44 (2003) 261-264
27. Rieux C., Carney R., Lupi D., Dkhissi-Benyahya O., Jansen K., Chounlamountri N., et al. Analysis of immunohistochemical label of Fos protein in the suprachiasmatic nucleus: comparison of different methods of quantification. J Biol Rhythms 17 (2002) 121-136
28. Kageyama M., Fukushima K., Togawa T., Fujimoto K., Taki M., Nishimura A., et al. Relationship between excretion clearance of rhodamine 123 and P-glycoprotein (Pgp) expression induced by representative Pgp inducers. Biol Pharm Bull 29 (2006) 779-784
29. Turncliff R.Z., Tian X., and Brouwer K.L. Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes. Biochem Pharmacol 71 (2006) 1520-1529
30. Löscher W., and Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2 (2005) 86-98
31. Dogan A.L., Legrand O., Faussat A.M., Perrot J.Y., and Marie J.P. Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemic cell lines. Leuk Res 28 (2004) 619-622
32. Alqawi O., Bates S., and Georges E. Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding. Biochem J 382 (2004) 711-716
33. Eyal S., Lamb J.G., Smith-Yockman M., Yagen B., Fibach E., Altschuler Y., et al. The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver. Br J Pharmacol 149 (2006) 250-260
34. Weiss J., Kerpen C.J., Lindenmaier H., Dormann S.M., and Haefeli W.E. Interaction of antiepileptic drugs with human P-glycoprotein in vitro. J Pharmacol Exp Ther 307 (2003) 262-267
35. Rogawski M.A., and Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10 (2004) 685-692
36. Stefan H., and Feuerstein T.J. Novel anticonvulsant drugs. Pharmacol Ther 113 (2007) 165-183
37. Sun J.J., Xie L., and Liu X.D. Transport of carbamazepine and drug interactions at blood-brain barrier. Acta Pharmacol Sin 27 (2006) 249-253
38. Baltes S., Gastens A.M., Fedrowitz M., Potschka H., Kaever V., and Löscher W. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 52 (2007) 333-346
39. Handschin C., and Meyer U.A. Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev 55 (2003) 649-673
40. Cerveny L., Svecova L., Anzenbacherova E., Vrzal R., Staud F., Dvorak Z., et al. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos 35 (2007) 1032-1041
41. Faucette S.R., Zhang T.C., Moore R., Sueyoshi T., Omiecinski C.J., LeCluyse E.L., et al. Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J Pharmacol Exp Ther 320 (2007) 72-80
42. Giessmann T., May K., Modess C., Wegner D., Hecker U., Zschiesche M., et al. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. Clin Pharmacol Ther 76 (2004) 192-200
43. Jackson J.P., Ferguson S.S., Negishi M., and Goldstein J.A. Phenytoin induction of the cyp2c37 gene is mediated by the constitutive androstane receptor. Drug Metab Dispos 34 (2006) 2003-2010
44. Chen Y., Ferguson S.S., Negishi M., and Goldstein J.A. Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J Pharmacol Exp Ther 308 (2004) 495-501
45. Owen A., Goldring C., Morgan P., Park B.K., and Pirmohamed M. Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements. Br J Clin Pharmacol 62 (2006) 237-242
46. Bauer B., Hartz A.M., Fricker G., and Miller D.S. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 66 (2004) 413-419
47. Owen A., Pirmohamed M., Tettey J.N., Morgan P., Chadwick D., and Park B.K. Carbamazepine is not a substrate for P-glycoprotein. Br J Clin Pharmacol 51 (2001) 345-349